Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
The federal government has called for an immediate pause in the usage of the Johnson & Johnson COVID-19 vaccine. The move comes after six women developed rare blood clots after receiving the vaccine. Nearly 7 million people have received the Johnson & Johnson vaccine in the United States so far.
What does the move mean for those who have received the one dose vaccine and how will it affect the U.S. vaccination rollout? PBS NewsHour’s Amna Nawaz posed these questions — and yours — to data and health reporter Laura Santhanam on Tuesday.
READ MORE: U.S. recommends ‘pause’ for J&J vaccine over clot reports
WATCH: FDA, CDC experts answer questions about pause on Johnson & Johnson vaccine
Laura Santhanam is the Data Producer for the PBS NewsHour. Follow @LauraSanthanam
Amna Nawaz joined PBS NewsHour in April 2018 and serves as the program's chief correspondent and primary substitute anchor.
Support Provided By:
Additional Support Provided By: